Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations

Clinical Therapeutics

Volumn 31, Issue 5, 2009, Pages 1056-1063

  Friedman, Howard S ^a   Eid, Nemr S ^b   Crespi, Simone ^c   Wilcox, Teresa K ^d   Reardon, Gregory ^e  

^a Analytic Solutions LLC   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNITED BIOSOURCE CORPORATION   (United States)

^e Informagenics LLC   (United States)

Author keywords

asthma; asthma treatment guidelines; fluticasone; inhaled corticosteroids; pediatrics; salmeterol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST;

ARTICLE; ASTHMA; DISEASE SEVERITY; DRUG COST; FOOD AND DRUG ADMINISTRATION; HEALTH INSURANCE; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; UNITED STATES;

ALBUTEROL; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG LABELING; DRUG UTILIZATION; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 67049132992     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.05.008     Document Type: Article

References (17)

1. US Dept of Health & Human Services (HHS), National Heart, Lung, and and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR-3) [HHS Web site]. http://www.nhIbi.nih.gov/guidelines/asthma/index.htm Accessed April 16, 2008
2. Global Initiative for Asthma (GINA). GINA report, global strategy for asthma management and prevention [GINA Web site]. http://www.ginasthma.org/Guidelineitem.asp?I1=2&I2=1&intId=60 Accessed December 6, 2006
3. US Food and Drug Administration (FDA). Advair Diskus, Advair HFA, Brovana, Foradil, Perforomist, Serevent Diskus, and Symbicort Information (Long Acting Beta Agonists) [FDA Web site]. http://www.fda.gov/cder/drug/infopage/LABA/default.htm Accessed December 4, 2006
4. Nelson H.S., Weiss S.T., Bleecker E.R., et al., the SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol [published correction appears in Chest. 2006;129:1393]. Chest. 129 (2006) 15-26
5. Salpeter S.R., Buckley N.S., Ormiston T.M., and Saltpeter E.E. Meta-analysis: Effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 144 (2006) 904-912
6. Bisgaard H. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature. Pediatr Pulmonol. 29 (2000) 221-234
7. Bisgaard H., and Szefler S. Long-acting beta2 agonists and paediatric asthma. Lancet 367 (2006) 286-288
8. Breton M.C., Lelorier J., Forget A., and Blais L. Use of combination therapy in asthma: Are they prescribed according to guidelines. Respir Med. 101 (2007) 1916-1923
9. Helm M.E., Vargas P.A., and Jones S.M. Advair® prescribing patterns in a state Medicaid and child health insurance program. J Allergy Clin Immunol. 119 (2007) S170
10. Aaronson D.W. The "black box" warning and allergy drugs. J Allergy Clin Immunol. 117 (2006) 40-44
11. Friedman H.S., and Yawn B.P. Resource utilization in asthma: Combined fluticasone propionate/salmeterol compared with inhaled corticosteroids. Curr Med Res Opin. 23 (2007) 427-434
12. Pearlman D.S., Kottakis J., Till D., and Della Cioppa G. Formoterol delivered via a dry powder inhaler (Aerolizer): Results from long-term clinical trials in children. Curr Med Res Opin. 18 (2002) 445-455
13. Weinstein S.F., Pearlman D.S., Bronsky E.A., et al. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma. Ann Allergy Asthma Immunol. 81 (1998) 51-58
14. Tal A., Simon G., Vermeulen J.H., et al. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol. 34 (2002) 342-350
15. Sorkness C.A., Lemanske Jr. R.F., Mauger D.T., et al., the Childhood Asthma Research and Education Network of the National, Heart, Lung, and Blood Institute. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial [published correction appears in J Allergy Clin Immunol. 2007;120:285]. J Allergy Clin Immunol. 119 (2007) 64-72
16. Zimmerman B., D'Urzo A., and Bérubé D. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma. Pediatr Pulmonol. 37 (2004) 122-127
17. Li H.T., Zhang T.T., Zhou H., et al. Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma. Respiration 74 (2007) 33-43